From Cancer Research to a Breakthrough in Fibrosis Treatment
From Cancer Research to a Breakthrough in Fibrosis Treatment Haaretz
From Cancer Research to a Breakthrough in Fibrosis Treatment Haaretz
Neuroendocrine Prostate Cancer Market to Witness Growth at a 25% CAGR by 2036 Due to the Emergence of Emerging agents, including DLL3-targeted Therapies, ADCs, BsAbs, CAR-Ts, Aurora Kinase Inhibitors, and EZH2 Inhibitors | DelveInsight PR Newswire
От мухи к человеку: ученые нашли общий механизм развития рака Наука Mail
Белорусские ученые развивают персонализированную терапию и клеточное лечение рака Минская правда
Newsweek Names World’s Best Cancer Centers for 2027 Oncology News Central
2026 Stanford Cancer Institute Annual Report Stanford Medicine
Few patients who receive tumor-infiltrating lymphocyte therapy for advanced melanoma experience serious treatment-related adverse events after discharge. An evaluation of more than 50 individuals who received tumor-infiltrating lymphocyte (TIL) therapy at Memorial Sloan Kettering Cancer Center showed only two…
An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after childbirth. Cabergoline, a medication used to stop milk production after pregnancy loss or when breastfeeding is not possible, is generally well tolerated by patients with few side effects. But…
Eisai Deepens Its Oncology Evidence Base at ESMO Congress 2026 BioSpace
«Опухоль растет»: Гинеколог развеяла распространенный миф о раке яичников Radio1.ru
«Опухоль растет»: Гинеколог развеяла распространенный миф о раке яичников Radio1.ru
Yale Cancer Center, BioCT to host oncology summit in New Haven Hartford Business Journal
Virginia Cancer Specialists Expands Fauquier Cancer Care Center in Warrenton citybiz
Рак груди: какие симптомы нельзя игнорировать и когда нужно проверяться Inkazan.ru